Ignite Creation Date:
2025-12-24 @ 2:54 PM
Ignite Modification Date:
2026-01-01 @ 10:59 AM
Study NCT ID:
NCT03652259
Status:
TERMINATED
Last Update Posted:
2025-09-10
First Post:
2018-08-28
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Gene Delivery Clinical Trial of SRP-9003 (Bidridistrogene Xeboparvovec) for Participants With Limb-Girdle Muscular Dystrophy, Type 2E (LGMD2E) (Beta-Sarcoglycan Deficiency)
Sponsor:
Sarepta Therapeutics, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-10-27
Start Date Type:
ACTUAL
Primary Completion Date:
2025-01-14
Primary Completion Date Type:
ACTUAL
Completion Date:
2025-01-14
Completion Date Type:
ACTUAL
First Submit Date:
2018-08-28
First Submit QC Date:
None
Study First Post Date:
2018-08-29
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-09-03
Last Update Post Date:
2025-09-10
Last Update Post Date Type:
ESTIMATED